Tyler C. Hammond
About
In The Last Decade
Tyler C. Hammond
19 papers receiving 378 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 200
- Physiology 178
- Biological Psychiatry 60
- Psychiatry and Mental health 47
- Neurology 46
Countries citing papers authored by Tyler C. Hammond
This map shows the geographic impact of Tyler C. Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler C. Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler C. Hammond more than expected).
Fields of papers citing papers by Tyler C. Hammond
This network shows the impact of papers produced by Tyler C. Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler C. Hammond. The network helps show where Tyler C. Hammond may publish in the future.
Co-authorship network of co-authors of Tyler C. Hammond
This figure shows the co-authorship network connecting the top 25 collaborators of Tyler C. Hammond. A scholar is included among the top collaborators of Tyler C. Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler C. Hammond. Tyler C. Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 8 | |
| 3 | 9 | |
| 4 | 16 | |
| 5 | 14 | |
| 6 | 13 | |
| 7 | Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer's Disease than Amyloid or Tau. | 15 |
| 8 | 11 | |
| 9 | 17 | |
| 10 | 21 | |
| 11 | 21 | |
| 12 | β-amyloid and tau drive early Alzheimer’s disease decline while glucose hypometabolism drives late decline | 2 |
| 13 | 82 | |
| 14 | 1 | |
| 15 | 1 | |
| 16 | 105 | |
| 17 | 27 | |
| 18 | 0 | |
| 19 | 1 | |
| 20 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.